BTEC 2017 Annual Conference

Brain tumor epidemiology in the era of precision medicine

Evolving Evidence on Tumor and Germline Genetic Classification of Gliomas: Implications for Etiology and Survival Studies

Banff Conference Center

Alberta, Canada

June 27-29, 2017

Tuesday, June 27th

6:00-8:00 pm Reception at the Walter Phillips Gallery

Wednesday, June 28th

8:00–8:30 am Welcome coffee: Professional Development Centre, Banff, Canada

8:15–8:30 am Badge pick-up at the registration desk

8:30–8:35 am Welcome Remarks

8:35–9:35 am Keynote lecture: Daniel Brat MD, PhD, Emory University School of Medicine, Atlanta GA (Introduction by Johannes Hainfellner)

Diagnostic classification of brain tumors: separating wheat from the chaff

9:35–10:35 am Keynote lecture: Sharon Savage, MD, National Cancer Institute, Washington DC (Introduction by Ching Lau)

The promise and process of precision medicine in the post-GWAS era

10:45–11:00 am Coffee break

11:00–12:00 pm Keynote lecture: Christoph Bock, MD, Research Center for Molecular Medicine, Vienna, Austria (Introduction by Adelheid Wöhrer, MD, PhD)

Personal Genomes and Omics Profiling: Discovering individualized relevant diagnostic information in a sea of data

12:00–1:30 pm Lunch Buffet and BTEC Advisory Board Meeting

1:30–2:00 pm ABTA Junior Investigator abstract winner lectures

1:30 – 1:45 pm Adalberto Miranda Filho, International Agency for Research on Cancer, Lyon, France

Global epidemiology of brain and central nervous system cancers

1:45–2:00 pm Maral Adel Fahmideh, Karolinska Institutet, Stockholm, Sweden

Common Genetic Variations in Cell Cycle and DNA Repair Pathways Associated with Pediatric Brain Tumor Susceptibility

2:00–2:30 pm Keynote lecture: Elizabeth Claus, MD, PhD, Yale University, New Haven, CT

Partnership with a Patient Organization to Implement Web

Based Enrollment for Studies in Neuro-Oncology

2:30–3:00 pm Keynote lecture: Kimberly Johnson, MPH, PhD, Washington University, St Louis, MO

The promise and perils of international patient registries

3:00–4:00 pm Panel discussion: Carol Kruchko, Daniel Brat, MD, PhD, Jill Barnholtz-Sloan, PhD

Biomarkers for Cancer Registries: Changing needs

4:00–4:15 pm Coffee Break

4:15–5:30 pm Abstract presentations

Chairs: Kimberly Johnson, MPH, PhD and Michael Scheurer, PhD

4:15–4:30 pm Maria Feychting, PhD, Karolinska Institutet, Stockholm, Sweden

Maternal diabetes and incidence of childhood cancer - A nationwide cohort study in Sweden from 1973 to 2010

4:30–4:45 pm Beatrice Melin, MD, Umeå University, Umeå, Sweden

Genome-wide association study reveals specific differences in genetic susceptibility to glioblastoma and non-glioblastoma

4:45–5:00 pm Joseph Wiemels, PhD, University of California San Francisco, San Francisco CA, USA

Maternal cytomegalovirus infections during pregnancy and risk of childhood central nervous system tumors

5:00–5:15 pm Adelheid Woehrer, MD, PhD, Medical University of Vienna, Vienna, Austria

Patterns of Diagnostic Marker Assessment in Adult Diffuse Glioma: a Survey of the European Confederation of Neuropathological Societies (Euro-CNS)

5:15–5:30 pm David Solomon, MD, PhD, University of California San Francisco, San Francisco, CA

Targeted NGS of paired tumor and normal DNA reveals frequent cancer predisposing germline alterations in neuro-oncology patients

8:30 pm Conference Dinner

The Bison restaurant & Terrace - 210-211 Bear Street  - The Bison Courtyard


Thursday, June 29th

8:00–8:30 am Welcome coffee

8:30–9:30 am Keynote lecture: Hubert Caron, MD, PhD, Roche, Basel Switzerland (Introduction by Ching Lau)

Challenges and opportunities for childhood brain cancer therapies: What are the key targets?

9:30–10:30 am Keynote lecture: Gregory Cairncross MD, University of Calgary, Calgary, Canada (Introduction by Michael Scheurer)

Molecular classification of glioma as a key to precision guided treatments

10:30–10:45 am Coffee Break

10:45–12:00 pm Abstract Presentations

Chairs: Adelheid Wöhrer, MD, PhD and Judy Schwartzbaum, PhD

10:45–11:00 am Faith Davis, PhD, University of Alberta School of Public Health, Alberta, Canada

Socioeconomic Status, Urban-Rural Residence, and Brain Cancer Survival in Canada: 1996 – 2008

11:00–11:15 am Yoshitaka Narita, National Cancer Center Hospital, Tokyo, Japan Survival and clinical characteristics of patients with gliomas from the Brain Tumor Registry of Japan in 2005-200811:30–11:45 am Michael E. Scheurer, PhD, Baylor College of Medicine, Houston, TX

Chromosomally-Integrated Human Herpesvirus-6 in Familial Glioma

11:45–12:00 pm Annette Molinaro, PhD, University of California San Francisco, San Francisco, USA

Expanding the predictive ability of an interpretable tree

12:00–2:00 pm Lunch

BTEC Business Meeting (Open)

2:00–4:00 pm Working Group meetings in two sessions –

2 Working Groups per session for 1.5 hours each

4:00–4:30 pm Coffee Break

4:30–5:15 pm Working Group reports